Product Images Pregabalin Capsules, Cv
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 30 images provide visual information about the product associated with Pregabalin Capsules, Cv NDC 69097-683 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a formula to estimate creatinine clearance based on age, weight, and serum creatinine level, with a correction factor for female patients. However, there appears to be a typo in the formula - "ferale" should be "female".*
This is a chart showing the percentage of patients who improved, with respect to pain, after treatment. The X-axis displays the range of values from 0 to 290, while the Y-axis displays the percentage of patients improved.*
This text is not clear. It seems to contain some errors which makes it difficult to understand the context. Therefore, the description cannot be generated.*
This appears to be a graph or chart showing the percentage of patients who experienced improvement in pain after taking a medication called "Pragabaln" at a dosage of 100mg per day. The chart also includes a line graph showing the percentage improvement in pain from baseline.*
This is a report showing the "Responder Rate" percentage, with a value of 60%. Additional data is present but is unclear due to errors affecting the numbers and units.*
This is a graph displaying the percent of patient improvement in pain from baseline for three different daily doses of Pregabalin and a placebo. There are no additional details available.*
This appears to be a graph or chart displaying the percentage of subjects who improved over a 12-week period, with Pregabaline and Placebo as the two compared treatments. The x-axis runs from 0 to 20, and it seems that the y-axis indicates percentages. However, without further context or a clearer image, it is impossible to provide a more detailed description or interpretation of the data.*
Not available. The text appears to be a mixture of random characters, symbols, and numbers and does not provide any useful information.*
This is a medication called Pregabalin presented in capsule form. Each capsule contains 53G of Pregabal IS and is accompanied by prescribing information. The instructions indicate that the medication should be stored at a temperature of 15-20°C/, and that it should only be dispensed to patients with a accompanying medication guide. Additionally, a batch overprinting area is provided for later commercial packing.*
This is a prescription drug called Pregabalin. It is available in the form of capsules manufactured by Cipla Ltd, Kurkumbh, India. The drug should be stored at a temperature between 15°C to 30°C and should be kept out of the reach of children. The medication guide must be dispensed to each patient. The text also includes manufacturing and batch details.*
This is a medication packaging for Pregabalin 75 mg capsules manufactured by Gipla USA, Inc. The medication guide must be dispensed to each patient. The storage temperature of the medication is between 15°C to 30°C. It's important to keep out of reach of children. The direction of unwinding is not available.*
This is a description of Pregabalin capsules manufactured by Cipla USA, Inc. The capsules come in 100 mg strength and contain Pregabalin USP. The medication guide must be dispensed by the pharmacist to each patient. The capsules must be stored at 25°C (77F) and kept out of reach of children. The unwinding direction, batch overprinting area, and expiry details are also included on the packaging.*
This is a description of a medication called Pregabalin. It comes in the form of capsules, with each capsule containing 150mg of Pregabalin USP. It is manufactured by Cipla Ltd in Kurkumbh, India, and is distributed by Cipla USA, Inc. The medication is only available with a prescription and must be dispensed in child-resistant containers. The pharmacist's address is provided for reference. Additionally, the medication guide should be provided to each patient. There is an area for batch overprinting, which includes the serial number, expiry, and lot number during commercial packing. It should be stored at 25°C and can be stored at a range of 15°C-30°C.*
This is a description of a medication called Pregabalin. It is available in capsule form and each capsule contains 225mg Pregabalin. The medication should be stored in a child-resistant container at a temperature of 15°C-30°C. It is manufactured by Clpla Ltd in India and distributed in the USA by Clpla USA, Inc. The pharmacist is advised to dispense the medication guide to each patient. There is additional text related to batch overprinting in a commercial packing area.*
This is a medication label for Pregabalin capsules manufactured by Clpla Ltd. The capsules are intended for RxOnly use and should be stored at room temperature. The label contains dosage and usage instructions and advises to keep the medication in a child-resistant container out of reach of children. The label also provides the manufacturing location for the capsules and the address of the manufacturer. A medication guide should be included with each prescription. There is a section for batch overprinting that includes serial number, expiry, and lot number.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.